Adult Hip Dysplasia: An assessment tool for early diagnosis v1
Research type
Research Study
Full title
Developing and evaluating an assessment tool for Physiotherapists to improve and accelerate the diagnosis of Adult Hip Dysplasia and fast-track correct patient treatment.
IRAS ID
183604
Contact name
Elizabeth Evans
Contact email
Sponsor organisation
Cardiff University
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
TITLE: Adult Hip Dysplasia: An assessment tool for early diagnosis v1.
Adult hip dysplasia (AHD) involves a deformity of the hip joint which causes premature, secondary osteoarthritis (OA). AHD is under-recognised; average diagnostic delays of more than 5 years have been identified. Most patients are young and highly active; symptoms impact enormously on their lives. Joint conservation surgery through reconstruction is the preferred treatment but this needs to be done before arthritic damage occurs. Delayed diagnosis increases the likelihood of OA which typically means that patients as young as just 18 years of age require total hip replacement (THR). Misdiagnosis also has cost implications because patients receive repeated GP and physiotherapy appointments. It is therefore imperative that we raise awareness of the condition and develop diagnostic tools to detect AHD much earlier in order to preserve the hip joint.
Expert diagnostic assessment procedures are not currently documented nor available to non-specialists. The PhD study will address this by capturing specialists’ knowledge, together with detailed patient information to produce a comprehensive clinical picture from which an assessment tool will be configured, enabling quicker recognition of AHD.
A five-phased multi-method approach will be used:
Phase 1: A systematic review of the literature taking a narrative approach.
Phase 2: Collection of AHD Specialists’ assessment and clinical reasoning plus collection of patient reported signs, symptoms and impact of ADH.
Phase 3: Delphi Study to gain consensus and establish agreement of the condition’s features between AHD Specialists and between people with AHD.
Phase 4: Analysis and synthesis of data to establish the components of the assessment tool. Clinical testing of tool prototype for efficiency and sensitivity.
Phase 5: Dissemination of the findings in clinical, patient and research arenas, to improve understanding of AHD and promote use of the assessment tool.REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
16/SW/0162
Date of REC Opinion
3 Jun 2016
REC opinion
Further Information Favourable Opinion